#USA #Toronto #Oncology Trials #Xtalks #ASCO 2026

Insights from the Post-ASCO 2026 Webinar on Oncology Trials

As the landscape of oncology trials becomes increasingly complex, the upcoming webinar titled Post-ASCO 2026 Insights: Trial Development and Execution Strategies promises to provide invaluable guidance for industry professionals. Hosted by Xtalks, this free session is set to take place on June 16, 2026, at 11 AM EDT.

Key Takeaways for Attendees

Participants will delve into multifaceted aspects of modern oncology trials, including:

• - Biomarker strategies and their significance in trial execution.
• - Innovative modalities and multi-cohort designs that introduce inherent risks.
• - The importance of early operational planning to align scientific insights with clinical ambitions.

In an environment where competition is fierce and timelines are tight, delays are often exacerbated by operational challenges rather than scientific ones. The webinar aims to equip attendees with practical strategies for translating the scientific insights from the ASCO conference into actionable trial development and execution plans.

Importance of Strategic Operational Planning

The featured experts will highlight how the complexities of protocols and cohort design affect trial decisions and operational planning. They will discuss the critical intersection of scientific and operational domains and how they impact the overall flow of the trial process. For instance, attendees will learn:

• - How to manage oversight effectively.
• - The significance of vendor coordination and the smooth flow of data.
• - Strategies for addressing site activation as part of a more extensive execution framework.

Learn from the Experts

This webinar will be graced by several prominent figures in oncology, including:

• - Andrew Zupnick, PhD, Vice President of Oncology Drug Development at Worldwide Clinical Trials.
• - Heidi Gillenwater, MD, Senior Vice President of Clinical Development at Adcentrx Therapeutics.
• - Elise Horvath Walsh, MD, Vice President of Clinical Development at Kumquat Bioscience.
• - Victor Moreno, MD, PhD, Director of Clinical Research for Early Phase Trials Unit at START Madrid-FJD.

Their expertise will provide attendees with insights that go beyond mere data, connecting emerging scientific trends in oncology with the practical implications for planning and executing drug trials.

What Attendees Can Expect

By engaging in this webinar, participants will gain:

• - A deeper understanding of how to navigate the intricate landscape of oncology trials.
• - Skills to turn ASCO insights into practical execution strategies, which can significantly enhance the efficiency and success of their clinical programs.
• - Connections with like-minded professionals and leaders in the field.

To ensure their participation in this informative session, professionals interested in advancing their knowledge of oncology trial execution should register by visiting the Xtalks website. This opportunity will afford attendees vital knowledge and tools to navigate the complexities of modern oncology trials effectively, ensuring their projects move forward with agility and confidence.

For more information on registration and event details, visit Xtalks' official site. Don't miss this chance to enhance your trial development strategy with insights drawn from one of the year's most important oncology conferences!